Somatic cell mutants resistant to retrovirus replication: Intracellular blocks during the early stages of infection

Molecular Biology of the Cell

Volumn 10, Issue 6, 1999, Pages 1705-1717

  Gao, Guangxia ^a   Goff, Stephen P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL ISOLATION; CHEMICAL MUTAGENESIS; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATIC CELL; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0033017025     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.6.1705     Document Type: Article

References (62)

1. Alin, K., and Goff, S.P. (1996). Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection. Virology 222, 339-351.
2. Best, S., Le, T.P., Towers, G., and Stoye, J.P. (1996). Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826-829.
3. Bowerman, B., Brown, P.O., Bishop, J.M., and Varmus, H.E. (1989). A nucleoprotein complex mediates the integration of retroviral DNA. Genes & Dev. 3, 469-478.
4. Braaten, D., Franke, E.K., and Luban, J. (1996). Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70, 3551-3560.
5. Brown, P.O., Bowerman, B., Varmus, H.E., and Bishop, J.M. (1987). Correct integration of retroviral DNA in vitro. Cell 49, 347-356.
6. Bukrinsky, M.I., Sharova, N., Dempsey, M.P., Stanwick, T.L., Bukrinskaya, A.G., Haggerty, S., and Stevenson, M. (1992). Active nudear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89, 6580-6584.
7. Casella, C.R., Raffini, L.J., and Panganiban, A.T. (1997). Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. Virology 228, 294-306.
8. Chopra, A., Thibodeau, J., Tam, Y.C., Marengo, C., Mbikay, M., and Thirion, J.P. (1990). New mouse somatic cell mutants resistant to cadmium affected in the expression of their metallothionein genes. J. Cell. Physiol. 142, 316-324.
9. Coffin, J.M., Hughes, S.H., and Varmus, H.E. (1997). Retroviruses, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
10. Craven, R.C., Leure-duPree, A.E., Weldon, R.A.J., and Wills, J.W. (1995). Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69, 4213-4227.
11. Crawford, S., and Goff, S.P. (1984). Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J. Virol. 49, 909-917.
12. Crawford, S., and Goff, S.P. (1985). A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J. Virol. 53, 899-907.
13. Darnell, J.J., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
14. DesGroseillers, L., and Jolicoeur, P. (1983). Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685-696.
15. Eglitis, M.A., Kantoff, P., Gilboa, E., and Anderson, W.F. (1985). Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science 230, 1395-1398.
16. Ellis, J., and Bernstein, A. (1989). Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration. J. Virol. 63, 2844-2846.
17. Funanage, V.L. (1982). Isolation and characterization of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-resistant mutants of the Chinese hamster ovary cell line. Mol. Cell. Biol. 2, 467-477.
18. Goff, S.P. (1996). Operating under a Gag order: a block against incoming virus by the Fv1 gene. Cell 86, 691-693.
19. Goldmacher, V.S., Anderson, J., Schulz, M.L., Blattler, W.A., and Lambert, J.M. (1987). Somatic cell mutants resistant to ricin, diphtheria toxin, and to immunotoxins. J. Biol. Chem. 262, 3205-3209.
20. Gupta, R.S., and Siminovitch, L. (1976). The isolation and preliminary characterization of somatic cell mutants resistant to the protein synthesis inhibitor-emetine. Cell 9, 213-219.
21. Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-371.
22. Hocevar, B.A., and Howe, P.H. (1996). Isolation and characterization of mutant cell lines defective in transforming growth factor-beta signaling. Proc. Natl. Acad. Sci. USA 93, 7655-7660.
23. Hsu, H.W., Schwartzberg, P., and Goff, S.P. (1985). Point mutations in the P30 domain of the gag gene of Moloney murine leukemia virus. Virology 342, 211-214.
24. John, J., McKendry, R., Pellegrini, S., Flavell, D., Kerr, I.M., and Stark, G.R. (1991). Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol. Cell. Biol. 11, 4189-4195.
25. Jolicoeur, P. (1979). The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top. Microbiol. Immunol. 86, 67-122.
26. Jolicoeur, P., and Baltimore, D. (1976). Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc. Natl. Acad. Sci. USA 73, 2236-2240.
27. Katoh, I., Yoshinaka, Y., Rein, A., Shibuya, M., Odaka, T., and Oroszlan, S. (1985). Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology 145, 280-292.
28. Kiernan, R.E., Ono, A., Englund, G., and Freed, E.O. (1998). Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72, 4116-4126.
29. Kinsella, T.M., and Nolan, G.P. (1996). Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413.
30. Kizhatil, K., and Albritton, L.M. (1997). Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J. Virol. 71, 7145-7156.
31. Laiho, M., Weis, F.M., Boyd, FT., Ignotz, R.A., and Massague, J. (1991). Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II. J. Biol. Chem. 266, 9108-9112.
32. Laiho, M., Weis, F.M.B., and Massague, J. (1990). Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265, 18518-18524.
33. Landau, N.R., and Littman, D.R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66, 5110-5113.
34. Lewis, P., Hensel, M., and Emerman, M. (1992). Human immuno-deficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053-3058.
35. Lewis, P.F., and Emerman, M. (1994). Passage through mitosis is required for oncoretroviruses but not for human immunodeficiency virus. J. Virol. 68, 510-516.
36. Lobel, L.I., Murphy, J.E., and Goff, S.P. (1989). The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J. Virol. 63, 2629-2637.
37. MacInnes, M.A., Friedrich, U., van Daalen Wetters, T., and Coffino, P. (1982). Quantitative forward-mutation specificity of mono-functional alkylating agents, ICR-191, and aflatoxin B1 in mouse lymphoma cells. Mutat. Res. 95, 297-311.
38. Mao, C., Davies, D., Kerr, I.M., and Stark, G.R. (1993). Mutant human cells defective in induction of major histocompatibility complex class II genes by Interferon gamma. Proc. Natl. Acad. Sci. USA 90, 2880-2884.
39. Markowitz, D., Goff, S.P., and Bank, A. (1988a). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
40. Markowitz, D., Goff, S.P., and Bank, A. (1988b). A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
41. Marsh, M., and Helenius, A. (1989). Virus entry into animal cells. Adv. Virus Res. 36, 107-151.
42. McKendry, R., John, J., Flavell, D., Muller, M., Kerr, I.M., and Stark, G.R. (1991). High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci. USA 88, 11455-11459.
43. -) salvage. In: Methods in Molecular Biology, ed. E.J. Murray, Clifton, NJ: Humana Press, 257-267.
44. Morgan, M.J., Colby, C.J., and Hulse, J.L. (1973). Isolation and characterization of virus-resistant mouse embryo fibroblasts. J. Gen. Virol. 20, 377-385.
45. Nakamura, N., and Okada, S. (1983). Mutations resistant to bromodeoxyuridine in mouse lymphoma cells selected by repeated exposure to EMS. Characteristics of phenotypic instability and reversion to HAT resistance by 5-azacytidine. Mutat. Res. 111, 353-364.
46. Naldini, L., Blomer, U., Gage, F.H., Trono, D., and Verma, I.M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
47. Nussbaum, O., Roop, A., and Anderson, W.F. (1993). Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J. Virol. 67, 7402-7405.
48. Ou, C.-Y., Boone, L.R., Koh, C.K., Tennant, R.W., and Yang, W.K. (1983). Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses. J. Virol. 48, 779-784.
49. Pellegrini, S., John, J., Shearer, M., Kerr, I.M., and Stark, G.R. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
50. Pryciak, P.M., and Varmus, H.E. (1992). Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J. Virol. 66, 5959-5966.
51. Ripka, J., and Stanley, P. (1986). Lectin-resistant CHO cells: selection of four new pea lectin-resistant phenotypes. Somat. Cell Mol. Genet. 12, 51-62.
52. Robbins, A.R., Oliver, C., Bateman, J.L., Krag, S.S., Galloway, C.J., and Mellman, I. (1984). A single mutation in Chinese hamster ovary cells impairs both Golgi and endosomal functions. J. Cell Biol. 99, 1296-1308.
53. Roe, T.-Y., Reynolds, T.C., Yu, G., and Brown, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
54. Schwartzberg, P., Colicelli, J., and Goff, S.P. (1984). Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: a new viral function required for productive infection. Cell 37, 1043-1052.
55. Smith, C.M., Potts, W.B., III, Smith, J.S., and Roth, M.J. (1997). RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology 229, 437-446.
56. Stanley, P., Sallustio, S., Krag, S.S., and Dunn, B. (1990). Lectinresistant CHO cells: selection of seven new mutants resistant to ricin. Somat. Cell Mol. Genet. 76, 211-223.
57. Taber, R., Alexander, V., and Wald, N.J. (1976). The selection of virus-resistant Chinese hamster ovary cells. Cell 8, 529-533.
58. van Zonneveld, A.J., Curriden, S.A., and Loskutoff, D.J. (1988). Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. USA 85, 5525-5529.
59. Velazquez, L., Fellous, M., Stark, G.R., and Pellegrini, S. (1992). A protein ryrosine kinase in the Interferon α/β signaling pathway. Cell 70, 313-322.
60. Verhasselt, B., De, S.M., Verhelst, R., Naessens, E., and Plum, J. (1998). Retrovirally transduced CD34+ + human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 91, 431-440.
61. Weinberg, J.B., Matthews, T.J., Cullen, B.R., and Malim, M.H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174, 1477-1482.
62. Yu, X., Yu, Q.C., Lee, T.H., and Essex, M. (1992). The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J. Virol. 66, 5667-5670.